Trade

with

Daxor Corp
(Amex: DXR)
AdChoices
6.57
+0.08
+1.23%
After Hours :
-
-
-

Open

6.54

Previous Close

6.49

Volume (Avg)

600 (3.96k)

Day's Range

6.54-6.57

52Wk Range

5.65-8.90

Market Cap.

26.50M

Dividend Rate (Yield )

0.20 (0.76%)

Beta

0.07

Shares Outstanding

4.03M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 1.84M

    • Net Income

    • -8.22M

    • Market Cap.

    • 26.50M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -274.59

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.07

    • Forward P/E

    • -

    • Price/Sales

    • 16.45

    • Price/Book Value

    • 1.04

    • Price/Cash flow

    • 16.23

      • EBITDA

      • 5.18M

      • Return on Capital %

      • -9.13

      • Return on Equity %

      • -13.86

      • Return on Assets %

      • -9.13

      • Book Value/Share

      • 6.32

      • Shares Outstanding

      • 4.03M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.05 (12/5/2013)

      • Dividend Declaration Date

      • 11/16/2013

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 2.30

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 0.91

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -36.90

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 52.83

            • Pre-Tax Margin

            • -418.63

            • 15.96

            • Net Profit Margin

            • -274.59

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.67

              • 0.62

              • Current Ratio

              • -

              • 1.97

              • Quick Ratio

              • -

              • 1.16

              • Interest Coverage

              • -

              • 10.47

              • Leverage Ratio

              • 1.77

              • 2.38

              • Book Value/Share

              • 6.32

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -5.92

                • 34.60

                • P/E Ratio 5-Year High

                • -13.78

                • 279.76

                • P/E Ratio 5-Year Low

                • -5.16

                • 148.87

                • Price/Sales Ratio

                • 16.26

                • 3.21

                • Price/Book Value

                • 1.03

                • 4.00

                • Price/Cash Flow Ratio

                • 16.23

                • 16.67

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -13.86

                    (-)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • -9.13

                    (-)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • -8.54

                    (-)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • -

                  • 25.65k

                  • Inventory Turnover

                  • -

                  • 2.66

                  • Asset Turnover

                  • 0.03

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  5.18M
                  Operating Margin
                  281.21
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  16.23
                  Ownership

                  Institutional Ownership

                  6.35%

                  Top 10 Institutions

                  6.35%

                  Mutual Fund Ownership

                  3.77%

                  Float

                  22.43%

                  5% / Insider Ownership

                  82.16%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    52,533

                  • 39.20

                  • 1.30

                  • DFA U.S. Micro Cap Portfolio

                  •  

                    43,502

                  • 0.00

                  • 1.08

                  • DFA U.S. Small Cap Portfolio

                  •  

                    14,561

                  • 0.00

                  • 0.36

                  • DFA Tax-Managed U.S. Targeted Value

                  •  

                    10,080

                  • 0.00

                  • 0.25

                  • DFA US Small Cap Value II Portfolio

                  •  

                    8,579

                  • 0.00

                  • 0.21

                  • DFA U.S. Core Equity II Fund

                  •  

                    5,407

                  • 0.00

                  • 0.13

                  • DFA U.S. Vector Equity Fund

                  •  

                    4,092

                  • 0.00

                  • 0.10

                  • Vanguard Balanced Index Fund

                  •  

                    3,969

                  • 0.00

                  • 0.10

                  • DFA Tax Managed U.S. Small Cap Portfolio

                  •  

                    3,400

                  • 0.00

                  • 0.08

                  • DFA US Core Equity I Fund

                  •  

                    2,013

                  • 0.00

                  • 0.05

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Dimensional Fund Advisors, Inc.

                  •  

                    149,934

                  • 0.00%

                  • 3.72

                  • Renaissance Technologies Corp

                  •  

                    47,400

                  • +0.64%

                  • 1.17

                  • Vanguard Group, Inc.

                  •  

                    41,870

                  • 0.00%

                  • 1.04

                  • California Public Employees Retrmnt Sys

                  •  

                    13,700

                  • 0.00%

                  • 0.34

                  • Morgan Stanley Smith Barney LLC

                  •  

                    1,189

                  • -5.03%

                  • 0.03

                  • Northern Trust Investments Inc.

                  •  

                    522

                  • 0.00%

                  • 0.01

                  • FMG LLC

                  •  

                    307

                  • 0.00%

                  • 0.01

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Distressed

                  Style

                  Small Core

                  Daxor Corp was originally incorporated in New York State as Iatric Corporation in May 1971for cryobanking services and continues these services through its wholly-owned subsidiary, Scientific Medical Systems. In October 1971, the nam...moree Iatric Corporation was changed to Idant Corporation. In May 1973, the name Idant Corporation was changed to Daxor Corporation. It is a medical device manufacturing Company, which offers additional biotech services, such as cryobanking, through its wholly owned subsidiary Scientific Medical Systems Corp. The main focus of the Company has been the development and marketing of an instrument that rapidly and accurately measures human blood volume. This instrument is used in conjunction with a single use diagnostic injection and collection kit that the Company also sells to...more its customers. The Company’s main focus has been on the development of the BVA-100(r) Blood Volume Analyzer, an instrument that rapidly and accurately measures human blood volume. The instrument is used in conjunction with Volumex(r), a single-use radiopharmaceutical diagnostic injection and collection kit. The BVA-100 has also been used to aid in the diagnosis and treatment of polycythemia, hypertension, anemia, chronic fatigue, and to aid in presurgical evaluation. Additional possible uses include management of kidney dialysis, ultrafiltration, and blood optimization for elective surgery. The Company’s marketing of the blood volume analyzer could be divided roughly into three phases: initial beta testing at local facilities, late-stage beta testing at nationally recognized institutions - with an emphasis on developing studies for publication, and marketing of the instrument for clinical use. During late-stage beta testing and the marketing phase, the instrument continued to experience a number of major technical improvements and alternations. It competes for customers based on a variety of factors, including reputation, customer service, performance, expertise, price and scope of service offerings.lessless

                  Key People

                  Dr. Joseph Feldschuh,M.D.

                  CEO/Chairman of the Board/Director/President

                  David Frankel

                  CFO/Chief Accounting Officer

                  Martin Wolpoff

                  Director

                  Robert Willens

                  Director

                  James Lombard

                  Director

                  • Daxor Corp

                  • 350 Fifth Avenue

                  • New York, NY 10118

                  • USA.Map

                  • Phone: +1 212 244-0555

                  • Fax: +1 212 244-0806

                  • daxor.com

                  Incorporated

                  1971

                  Employees

                  750

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: